Psychiatrists With Ties to AstraZeneca Resign From Texas State Hospital
By  ED SILVERMAN Bloomberg NewsTwo psychiatrists at a Texas state hospital have resigned after being told they would face disciplinary actions for accepting hundreds of thousands of dollars in speaking and consulting fees from AstraZeneca AZN +1.58% while also promoting one of its drugs to state officials, according to a spokeswoman for the Texas Department of State Health Services.The psychiatrists allegedly violated various department rules as a result of their relationship to the drug maker, which involved efforts to ensure the Seroquel XR antipsychotic would be placed on the state formular...
Source: PharmaGossip - April 21, 2015 Category: Pharmaceuticals Authors: insider Source Type: blogs

Yes!
WHO calls for increased transparency in medical researchNote for the media14 April 201514 APRIL | 2015 GENEVA - WHO today issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result. The move aims to ensure that decisions related to the safety and efficacy of vaccines, drugs and medical devices for use by populations are supported by the best available evidence.“Our intention is to promote the sharing of scientific knowledge in order to advance public health,” said Dr. Marie-Paule Kieny, WHO Assistant Director General for Health Systems and Innovat...
Source: PharmaGossip - April 13, 2015 Category: Pharmaceuticals Authors: insider Source Type: blogs

Read it and weep - then get angry!
The Deadly Corruption of Clinical TrialsUpdate (4/3/2015):  After nearly 11 years of obfuscation and denial surrounding the tragic death of Dan Markingson, the University of Minnesota has suspended enrollment in psychiatric drug trials. This comes in response to a blistering report issued by the Minnesota State Legislative Auditor that cites "serious ethical issues" and vindicates much of the reporting in the story below. Read more from Carl Elliott about the fallout from the report here.IT'S NOT EASY TO WORK UP a good feeling about the institution that destroyed your life, which may be why Mary Weiss i...
Source: PharmaGossip - April 3, 2015 Category: Pharmaceuticals Authors: insider Source Type: blogs

Tales from the PMCPA contd. - The case of the beer drinking, lederhosen wearing, presenter
​A pulmonologist working in Germany, complained about a scientific symposium organised by Boehringer Ingelheim at the European Respiratory Society (ERS) Congress held in Munich.The symposium was part of the industry sponsored sessions.  It was advertised in the official meeting programme as ‘Slowing disease progression in IPF [idiopathic pulmonary fibrosis]: New evidence From Phase III clinical trials’.The complainant stated that his main complaint was that on the main stage, the speakers were allowed to drink beer – with one even dressed in lederhosen.  For a serious, fatal condition, this was not approp...
Source: PharmaGossip - February 19, 2015 Category: Pharmaceuticals Authors: insider Source Type: blogs

Last Week Tonight with John Oliver: Marketing to Doctors (HBO)
(Source: PharmaGossip)
Source: PharmaGossip - February 9, 2015 Category: Pharmaceuticals Authors: insider Source Type: blogs

Mother brought to tears hearing Johnson & Johnson's Risperdal tactics
David SellPosted: Friday, January 30, 2015, 8:05 AMBenita Pledger dabbed at her tears as she sat in a wooden chair outside a court room in Philadelphia's City Hall early Thursday evening."I'm just having a hard time right now," she said, "hearing what the pharmaceutical company was doing."Pledger had just finished a full day of listening to her attorney, Thomas Kline, and former U.S. Food and Drug Administration commissioner Dr. David Kessler discuss documents that showed Johnson & Johnson's Janssen Pharmaceutical subsidiary tried to manipulated data in versions of reports to hide evidence that the company's antip...
Source: PharmaGossip - January 29, 2015 Category: Pharmaceuticals Authors: insider Source Type: blogs

Mother brought to tears hearing Johnson & Johnson's Risperdal tactics
< h1 class="title" style="font: -apple-system-headline; font-weight: normal; -webkit-hyphens: manual; max-width: 100%;" > < br > < /h1 > < p style="max-width: 100%; font-weight: bold;" > < /p > < h5 style="margin: 1em 0px; font: -apple-system-caption2; max-width: 100%;" > < font face="Helvetica Neue Light, HelveticaNeue-Light, helvetica, arial, sans-serif" > < span style="font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);" > David Sell < /span > < /font > < /h5 > < span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);" > Posted: & nbsp; < span style="m...
Source: PharmaGossip - January 29, 2015 Category: Pharmaceuticals Authors: insider Source Type: blogs

NNT - The Website
http://www.thennt.com (Source: PharmaGossip)
Source: PharmaGossip - January 28, 2015 Category: Pharmaceuticals Authors: insider Source Type: blogs

A "must read" - Cargo Cult Science by Richard Feynman
From a Caltech commencement address given in 1974 Also in Surely You're Joking, Mr. Feynman!During the Middle Ages there were all kinds of crazy ideas, such as that a piece of of rhinoceros horn would increase potency. Then a method was discovered for separating the ideas--which was to try one to see if it worked, and if it didn't work, to eliminate it. This method became organized, of course, into science. And it developed very well, so that we are now in the scientific age. It is such a scientific age, in fact, that we have difficulty in understanding how witch doctors could ever have existed, when nothing that...
Source: PharmaGossip - September 1, 2014 Category: Pharma Commentators Authors: insider Source Type: blogs

Cancer Drugs Fund receives boost but will no longer fund “overpriced” drugs = BMJ
Cancer Drugs Fund receives boost but will no longer fund “overpriced” drugsBMJ 2014; 349 doi: http://dx.doi.org/10.1136/bmj.g5382 (Published 01 September 2014)Cite this as: BMJ 2014;349:g5382Nigel HawkesThe Cancer Drugs Fund has been given a 40% increase in funding and has agreed to remove from its list any drugs that are overpriced or produce little clinical benefit. The fund’s chairman also promised to try to align the fund’s assessments more closely with those of the National Institute for Health and Care Excellence (NICE).NHS England, which is responsible for the drugs fund, has agreed to increase the amount th...
Source: PharmaGossip - September 1, 2014 Category: Pharma Commentators Authors: insider Source Type: blogs

Novartis fails to report side effects, fatality
6:52 pm, August 30, 2014Jiji PressNovartis Pharma K.K. said it has failed to report to the health ministry at least 2,579 cases of serious side effects, including a fatality, from its drugs for leukemia and other diseases even though its employees were aware of the problems.Of the total, 1,313 cases were related to Glivec and 514 cases to Tasigna, both drugs for leukemia treatment, and 261 cases involved cancer drug Afinitor, said the Japanese unit of Swiss drug giant Novartis AG on Friday.The findings were reported to the Health, Labor and Welfare Ministry the same day.Marketing employees at the firm had recognized the si...
Source: PharmaGossip - August 30, 2014 Category: Pharma Commentators Authors: insider Source Type: blogs

Mobile App Usage Surges. Will Pharma Ads Follow?
According to the 2014 U.S. Mobile App Report by Comscore, U.S. digital consumers now spend more time using mobile apps than they do  on desktop computers (see chart below)."Total U.S. digital media time spent has jumped 24 percent in the past year, driven by a surge in mobile app usage, which increased 52 percent," noted the report."While mobile usage has been growing fast, it has not come at the expense of desktop computer usage, which still managed to grow by 1 percent. Apps drive the vast majority of media consumption activity on mobile devices, accounting for approximately 7 out of every 8 minutes."...
Source: Pharma Marketing Blog - August 25, 2014 Category: Pharma Commentators Tags: Apps Mobile Advertising Source Type: blogs

A new blog to follow: Chaos Theory and Human Pharmacology
http://chaoticpharmacology.wordpress.com/ (Source: PharmaGossip)
Source: PharmaGossip - August 17, 2014 Category: Pharma Commentators Authors: insider Source Type: blogs

Pharmalot is THE BEST
http://blogs.wsj.com/pharmalot/ (Source: PharmaGossip)
Source: PharmaGossip - August 16, 2014 Category: Pharma Commentators Authors: insider Source Type: blogs

Illinois Suspends Michael Reinstein's Medical License
Michael Reinstein (Gerald Rich/ProPublica)Illinois medical regulators have indefinitely suspended the medical license of psychiatrist Michael Reinstein, who prescribed more of the most powerful and riskiest antipsychotic drug clozapine than any other doctor in the country.The decision by Illinois' Department of Financial and Professional Regulation, signed Friday, suspends Reinstein's license for a minimum of three years, at which time he can apply to have it reinstated.The state's medical disciplinary board recommended the sanction in May after determining that Reinstein, 71, received "illegal direct and indirec...
Source: PharmaGossip - August 16, 2014 Category: Pharma Commentators Authors: insider Source Type: blogs